PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.54%
Revenue growth similar to 3391.T's 2.54%. Walter Schloss would see if both companies share industry tailwinds.
2.13%
Gross profit growth at 50-75% of 3391.T's 3.66%. Martin Whitman would question if cost structure or brand is lagging.
-4.04%
Negative EBIT growth while 3391.T is at 8.40%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
8.13%
Operating income growth at 50-75% of 3391.T's 11.59%. Martin Whitman would doubt the firm’s ability to compete efficiently.
-4.25%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.26%
Negative EPS growth while 3391.T is at 2.21%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.26%
Negative diluted EPS growth while 3391.T is at 2.27%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3391.T is at 0.13%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.08%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.82%
10Y revenue/share CAGR under 50% of 3391.T's 122.66%. Michael Burry would suspect a lasting competitive disadvantage.
-10.63%
Negative 5Y CAGR while 3391.T stands at 74.89%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
34.92%
3Y revenue/share CAGR at 50-75% of 3391.T's 56.43%. Martin Whitman would question if the firm lags behind competitor innovations.
100.00%
Positive long-term OCF/share growth while 3391.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
189.89%
Net income/share CAGR at 50-75% of 3391.T's 325.34%. Martin Whitman might question if the firm’s product or cost base lags behind.
14.72%
Below 50% of 3391.T's 160.38%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
61.26%
3Y net income/share CAGR 75-90% of 3391.T's 78.78%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
132.27%
10Y equity/share CAGR in line with 3391.T's 146.28%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
27.36%
Below 50% of 3391.T's 90.47%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.35%
3Y equity/share CAGR 1.25-1.5x 3391.T's 46.34%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.78%
Firm’s AR is declining while 3391.T shows 4.42%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.34%
Inventory is declining while 3391.T stands at 3.66%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.61%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
3.83%
BV/share growth above 1.5x 3391.T's 2.38%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.07%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.53%
SG&A declining or stable vs. 3391.T's 1.40%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.